Position in GSK
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$873,946
-$668,007 QoQ
Shares Held
16,672
-40.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#370
of 1,032 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROCKLAND TRUST CO holds $129,433,318 across 10 Drug Manufacturers - General names. GSK ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
490,049 | $62,971,296 | |
| 2 | JNJ |
Johnson & Johnson
|
78,477 | $19,930,803 | |
| 3 | LLY |
ELI LILLY & Co
|
16,303 | $19,554,308 | |
| 4 | PFE |
Pfizer Inc
|
430,196 | $10,359,119 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
146,933 | $8,466,278 | |
| 6 | ABBV |
AbbVie Inc.
|
25,770 | $6,484,762 | |
| 7 | GSK |
GSK plc
This page
|
16,672 | $873,946 | |
| 8 | AMGN |
Amgen Inc
|
778 | $281,729 |
All Filings in GSK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $873,946 | 16,672 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,541,953 | 27,939 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $1,371,158 | 27,960 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,225,916 | 28,404 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||